Picker International's booth at the Society of Nuclear Medicinemeeting highlighted the vendor's second generation of productintroductions stemming from the launch of its simultaneous transmission-emissionprotocol (STEP) photon attenuation correction
Picker International's booth at the Society of Nuclear Medicinemeeting highlighted the vendor's second generation of productintroductions stemming from the launch of its simultaneous transmission-emissionprotocol (STEP) photon attenuation correction technique two yearsago.
The Cleveland company will introduce Converge, an investigationalenhancement to STEP that further improves image quality by fine-tuningthe geometric point response of the camera, according to JoshGurewitz, marketing manager.
Converge addresses partial volume effect, a form of image degradationcaused by differences in the physical distance between variouspoints of the targeted anatomy and the camera, Gurewitz said.It works by enhancing the remaining scatter component and correctingfor the point-spread function of the collimator, he said.
Converge will be available as an upgrade to STEP on the triple-headPrism 3000XP and will be a standard feature on a modificationof STEP earmarked for use on the dual-head Prism 2000XP. Internationalsales of the dual-head product will begin this summer. Food andDrug Administration 510(k) clearance is pending in the U.S.
Picker will also show NeuroFlow, a new xenon-133 brain imagingpackage for the 3000XP (SCAN 4/24/96). The FDA-cleared product,which quantifies regional cerebral blood flow, was developed withthe assistance of Dr. Michael Devous, associate director of nuclearmedicine at the University of Texas Southwestern Medical Centerin Dallas.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.